Axsome Therapeutics, Inc.
NASDAQ:AXSM
86.45 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -239.238 | -187.134 | -130.403 | -102.901 | -68.345 | -30.965 | -28.943 | -27.202 | -10.56 | -6.001 | -2.167 |
| Depreciation & Amortization
| 6.834 | 5.564 | 1.156 | 0.078 | 0.037 | 0.049 | 0.043 | 0.02 | 0.004 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.247 | 0 | -2.791 | 0.646 | 0 | 2.278 | 0 | 0 |
| Stock Based Compensation
| 62.62 | 37.726 | 20.803 | 14.756 | 6.115 | 1.755 | 2.072 | 2.031 | 0.803 | 0.377 | 0.055 |
| Change In Working Capital
| -28.392 | 23.669 | 0.325 | 0.412 | 15.168 | 1.523 | -0.76 | 3.8 | 0.938 | 0.515 | 0.153 |
| Accounts Receivables
| -57.121 | -37.699 | 0.006 | 0.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -8.156 | -5.275 | -0.006 | -0.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 2.074 | 25.456 | -0.355 | 2.561 | 7.256 | 0.252 | -0.646 | 2.189 | 1.134 | 0.599 | 0.158 |
| Other Working Capital
| 34.811 | 41.187 | 0.679 | -2.149 | 7.912 | 1.271 | -0.114 | 1.611 | -0.196 | -0.084 | -0.005 |
| Other Non Cash Items
| 53.096 | 3.663 | -0.105 | 7.951 | 0.65 | 0.376 | 0.471 | 0.069 | -0.902 | 0.513 | 0.327 |
| Operating Cash Flow
| -145.08 | -116.511 | -108.226 | -78.457 | -46.375 | -30.054 | -26.472 | -21.281 | -7.439 | -4.596 | -1.631 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.582 | -0.702 | -0.308 | -0.046 | -0.016 | -0.033 | -0.01 | -0.105 | -0.02 | 0 | 0 |
| Acquisitions Net
| 0 | -53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -53,702,109 | -307,549 | -45,891 | -16,121 | -32,696 | -9,898 | -104.561 | -0.02 | 0 | 0 |
| Investing Cash Flow
| -0.582 | -53.702 | -0.308 | -0.046 | -0.016 | -0.033 | -0.01 | -0.105 | -0.02 | 0 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 85 | 45 | 0 | 28.34 | 12.761 | -3.333 | -0.278 | 10 | 7.341 | 5.189 | 3.775 |
| Common Stock Issued
| 258.75 | 243.763 | 7.436 | 14.126 | 238.234 | 12.881 | 23.677 | 0.033 | 45.549 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -12.737 | -4.181 | 11,129,706.564 | -0.053 | 1.394 | 0.486 | 0.485 | -0.032 | -0.012 | -0.063 | -0.058 |
| Financing Cash Flow
| 331.013 | 284.582 | 11.13 | 42.413 | 252.389 | 10.034 | 23.884 | 9.968 | 52.878 | 5.126 | 3.717 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 185.351 | 114.369 | -97.404 | -36.09 | 205.997 | -20.052 | -2.597 | -11.418 | 45.418 | 0.53 | 2.086 |
| Cash At End Of Period
| 386.193 | 200.842 | 86.473 | 183.876 | 219.966 | 13.969 | 34.021 | 36.618 | 48.036 | 2.618 | 2.088 |